Search

everythinglearnresearchcommunity

for

Search:↓

Coating surfaces with human hair keratin improves the growth and consistency of important stem cells for medical use.

Bioactive molecules show promise for improving skin repair and regeneration by overcoming current challenges with further research.

Extracellular vesicles show promise for treating psoriasis by reducing inflammation and skin lesions.

Nanocarriers make melatonin more effective and reduce side effects.

A new treatment using hybrid vesicles with gold nanoparticles and finasteride significantly improves hair regrowth for androgenetic alopecia.

Using nanostructured lipid carriers to deliver spironolactone could improve treatment for hair loss.

Human hair-derived particles can effectively carry and release the cancer drug Paclitaxel in a pH-sensitive manner, potentially targeting cancer cells while sparing healthy ones.

New drug dutasteride effectively treats hair loss, but use cautiously due to potential sexual side effects.

CRISPR/Cas9 has improved precision and control but still faces clinical challenges.

The conclusion is that different treatments improved hair growth in dogs with Alopecia X, but results varied and not all dogs had complete hair regrowth.

Using CRISPR for gene editing in the body is promising but needs better delivery methods to be more efficient and specific.

Ethosomes improve drug delivery through the skin but may have side effects like irritation.

Sox6 is important in heart and kidney health, affecting diseases like diabetes, heart disease, and high blood pressure.

Different drug doses approved in Japan and the U.S. are not mainly due to different clinical responses, and ethnic factors should be considered in setting drug doses.

New liposome treatment successfully delivers CRISPR to deactivate a key enzyme in androgen-related disorders.

Nanotechnology shows promise for better drug delivery and cancer treatment.

HPV8 E6 gene causes growth of certain skin stem cells.

Chemicals and stem cells combined have advanced regenerative medicine with few safety concerns, focusing on improving techniques and treatment effectiveness.

Patient-derived melanocytes can potentially treat vitiligo by restoring skin pigmentation.

The conclusion is that hair growth can be improved by activating hair cycles, changing the surrounding environment, healing wounds to create new hair follicles, and using stem cell technology.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

Some patients with severe alopecia areata developed skin darkening from their treatment, which may indicate a less effective response to the therapy.

Microsponges delivery system is a safe, versatile method for controlled drug release in various treatments.

Antioxidants might help prevent pressure ulcers, but more research is needed to find effective ones.

Antimalarial agents are effective for LPP, and intralesional steroids are effective for FFA.

New drugs for Alzheimer's and rheumatoid arthritis advanced, a Zika vaccine is in development, and there were business deals in anesthesia and oncology.

Elidel combined with tretinoin is more effective for treating alopecia areata than Elidel alone.

MicroRNA-302 helps improve the conversion of body cells into stem cells by blocking NR2F2.

Platelet lysate is a promising, cost-effective option for regenerative medicine with potential clinical applications.

Ozone therapy might improve cancer treatment and reduce its side effects.